Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

Ajooni Biotech Limited

NSE: AJOONIAnimal Feed

Share price

₹3.03

+0.66% close of 9 Oct 2026

Market cap ₹52 CrP/E 12.9 (as of 8 Oct 2026)

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 9 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

65

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹52 Cr

P/E ratio

12.9

P/B ratio

0.6

ROCE

6.1%

ROE

4.5%

Dividend yield

0.0%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 9 Oct 2026 close52-week high ₹5.2152-week low ₹3.01

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 78.4% over the past year, and 24.4% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 4.6% to 3.5% over the last four years.

Whether it grew faster than its sector

It grew 24.4% a year against a sector median of 9.9% — 14.5 percentage points faster.

Room to re-rate, or risk of de-rating

At 12.9× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 18.2×, across 5 companies. It is against its own five-year median of 53.5×, the 0th percentile of its own range.

Whether growth justifies the valuation

Priced at 0.3 times its growth rate, on earnings growth of 51%.

Profit growthPrice per ₹1 profitPer 1% growth
Ajooni Biotech Limited — this one51%/yr12.9×₹0.25
Mukka Proteins Limited6%/yr11.3×₹1.9
KSE Limited191%/yr11.3×—
Narmada Agrobase Limited81%/yr23.6×₹0.29
Godrej Agrovet Limited23%/yr26.2×₹1.1
Avanti Feeds Limited28%/yr18.2×₹0.65

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Animal Feed), it ranks 6 of 6 on returns, 2 of 6 on growth, 6 of 6 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 6.1% on capital, ahead of 0% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

No — Over the last five years the business itself consumed ₹17 crore of cash before any plant spend, funded from lenders and shareholders. And the profit is not backed by cash: it reported a profit over 12 years and consumed cash from the business. Its cash comes back more slowly than it used to: it went from being waiting 58 days for its cash to waiting 93 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

6 of 9 checks clear · 67%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 14 Aug 2026 · Standalone · Unaudited

Revenue

₹63 Cr

Revenue vs last year

+103.0%

Revenue vs last quarter

+4.7%

Net profit

₹0 Cr

Profit vs last year

-44.6%

Profit vs last quarter

-54.5%

Net margin

0.7%

EPS

₹0.01

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹52 Cr
Prev close
₹3.03
52w High
₹5.5
52w Low
₹3.0
Enterprise value
₹70 Cr
Beta
1.0
Price CAGR 1y
-42.0%
Price CAGR 3y
-9.0%
Price CAGR 5y
-28.0%
Price CAGR 10y
—

Ratios

Return on assets
3.3%
PEG ratio
0.3
P/E ratio
12.9
P/B ratio
0.6
EV / EBITDA
11.6
Industry P/E
15.4
ROCE
6.1%
ROCE 5y average
6.8%
ROE
4.5%
Debt / Equity
0.2
Interest coverage
7.0
Dividend yield
0.0%
ROE 3y average
4.0%
ROE last year
4.0%

Annual P&L

Annual revenue
₹182 Cr
Annual profit
₹4 Cr
Operating margin
3.4%
Net profit margin
2.2%
EBITDA margin
3.3%
Sales growth 3y
35.0%
Sales growth 5y
29.0%
Profit growth 3y
51.0%
Profit growth 5y
60.0%
EPS
₹0.3
Sales growth TTM
78.0%
Profit growth TTM
8.0%
Dividend payout
0.0%

Quarter P&L

Sales latest quarter
₹63 Cr
Profit latest quarter
₹0 Cr
YoY quarterly sales growth
103.0%
YoY quarterly profit growth
-44.9%
OPM latest quarter
2.6%

Balance Sheet

Book Value
₹5.4
Face Value
₹2.0
Total debt
₹18 Cr
Total cash
₹0 Cr
Borrowings
₹18 Cr
Reserves / Equity
1.7

Cash Flow

Operating cash flow
-₹6 Cr
Free cash flow
-₹23 Cr
FCF yield
-45.0%
Net cash flow
-₹6 Cr

Shareholding

Promoter holding
30.5%
FII holding
0.0%
DII holding
—
Public holding
69.5%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Godrej Agrovet639.6026.212,3121.72128.3-16.22,855.29.219.2
Avanti Feeds722.3018.39,8441.38116.3-42.01,899.918.324.4
Mukka Proteins26.9411.88120.0018.61142.8489.7186.711.6
KSE176.8412.45697.070.9-98.4453.79.133.5
Shivam Chemicals145.0541.22460.004.2163.9152.617.616.6
Mayank Cattle Fo101.0018.11090.003.518.3217.82.915.8
Narmada Agrobase11.3523.9860.000.8-26.522.3100.98.9
Ajooni Biotech3.0113.1520.000.4-44.963.5103.06.1
Median160.9418.26910.6911.41.1471.713.417.9

Competes with: Avanti Feeds Limited, Godrej Agrovet Limited, KSE Limited, Mukka Proteins Limited, Narmada Agrobase Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Standalone · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales21192020262634293132596163
Expenses20192118252533283130566062
Material Cost232625484955
Change in Inventories0.11-0.040.07-0.14-0.01-0.39
Purchases of Stock-in-Trade000000
Employee Cost0.590.991.111.191.281.38
Other Expenses4.973.964.126.349.196.29
Operating Profit0.660.63-0.651.590.960.770.931.010.711.503.031.011.67
OPM %3.143.23-3.248.123.742.992.733.452.274.735.161.672.63
Other Income0.070.291.570.260.040.310.391.340.650.150.321.300.27
Exceptional items (within Other Income)000000
Interest0.130.190.120.110.150.060.070.060.080.170.180.290.48
Depreciation0.210.210.210.240.220.230.240.380.250.250.810.900.80
Profit before tax0.390.520.591.500.630.791.011.911.031.232.361.120.66
Tax %-2.56232439252328192424301535
Net Profit0.400.400.440.910.470.620.731.540.780.931.650.950.43
EPS in Rs0.020.020.030.050.030.040.040.090.050.050.100.060.02
Diluted EPS in Rs0.090.020.080.100.050.01

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Standalone · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7132942404051747480115182215
Expenses7132841393949717278111175207
Material Cost97148
Change in Inventories-0.13-0.13
Purchases of Stock-in-Trade00
Employee Cost2.764.57
Other Expenses1124
Operating Profit0011112332467
OPM %1.801.702.402.201.703.103.204.203.702.803.203.403.40
Other Income0-000000002222
Exceptional items (within Other Income)00
Interest-000000110100.731
Depreciation00000011111.092.213
Profit before tax00000001234.335.745
Tax %272928201529262828282225
Net Profit00000001123.374.324
EPS in Rs0.120.180.360.030.030.020.020.050.060.120.200.250.23
Diluted EPS in Rs0.200.25
Dividend Payout %-0-0-0-0-0-0-0-0-0-0-0-0

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
30%
5 years
29%
3 years
35%
TTM
78%

Compounded profit growth

10 years
44%
5 years
60%
3 years
51%
TTM
8%

Stock price CAGR

10 years
—
5 years
-28%
3 years
-9%
1 year
-42%

Return on equity

10 years
4%
5 years
4%
3 years
4%
Last year
4%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.240.240.33668101018183434
Reserves0015676624255457
Borrowings-0115557552218
Other Liabilities111141267123511
Total Liabilities22131918232829594895120
Fixed Assets001112566101126
CWIP-0-0-0-0-0-0-0-0010-0
Investments-0-06643114232
Other Assets126121318222248348092
Total Assets22131918232829594895120

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0-1-3-3-5-414-623-32-5.73
Cash from Investing Activity-0-0-2-010-3-2-16814-16
Cash from Financing Activity0158-132-222-42515
Net Cash Flow0-005-5-10-00276-6
Free Cash Flow-0-1-3-3-5-6-22-817-33-23

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days40331725441159868101595236
Inventory Days221463195134463439809097
Days Payable6627799122046395681322
Cash Conversion Cycle-42013584129986383131129111
Working Capital Days59-29-18410577589413215893
ROCE %2818371044596856

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Standalone · to 31 Aug 2026
Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Aug 2026
Promoters262627272727272727272731
FIIs0000.290.180000000
Public747473737373737373737369
No. of Shareholders30,93341,05351,22463,90664,10263,96863,30564,30562,69961,77960,67560,170

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -40.6% (₹5.10 → ₹3.03)Brick size ₹0.13 (fixed)Bricks 51
₹4.00₹5.00₹3.03Dec '25Feb '26Apr '26Jul '26Sep '26
Price moved up one brickPrice moved down one brickLast close ₹3.03 on 9 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

News

News and filings about Ajooni Biotech Limited. Open one to see why it matters.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • bran
  • cotton cake
  • maize
  • molasses
  • mustard cake
  • rice bran
  • soybean meal

Depends on the price of

  • corn

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Fast Moving Consumer Goods
Industry
Animal Feed
Classification
Fast Moving Consumer Goods › Animal Feed
ISIN
INE820Y01021

Plants

  • Khanna Plant - GT Road, Khanna
  • Mohali Plant - Plot No. D-118, Industrial Area, Phase 7

News impact

Big market events that reach Ajooni Biotech Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

7 Oct 2022split₹0

Splits, bonuses & buybacks

  • daily-prices repair: 23 rows from NSE's archive (replace 17, delete 1, insert 5), 2018-11-14..2026-02-01 (docs/flat_day_repair.md)1× · 14 Nov 2018

Bulk & block deals

DateWhoBought / soldSharesPrice
7 Sep 2026ANANTHARAMAN JANAKISELL10,73,331₹3.57

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.